SEALX - Online request for information for physicians
Please find below additional information about the study for the participants:
The study consists of applying an investigational topical gel twice daily for 8 weeks. You will be given either the ALX-101 Gel 5% drug or a placebo. This study treatment is experimental, and you will have 50% chance of receiving the placebo. This is a blinded study, so you and the study doctor will not know which treatment you are receiving.
Photographs of your atopic dermatitis will be taken throughout the study.
This study will last a period of up to 3 months and includes 6 visits. Visits take approximately 1 to 2 hours each, except for the screening visit which may take up to 3 hours.
Study participants will be compensated up to 450$
If you are interested in this study for your patients, please click Next below and answer the required questions.